medmix Future Growth

Future criteria checks 4/6

medmix is forecast to grow earnings and revenue by 59.6% and 4% per annum respectively. EPS is expected to grow by 59.4% per annum. Return on equity is forecast to be 12.6% in 3 years.

Key information

59.6%

Earnings growth rate

59.4%

EPS growth rate

Medical Equipment earnings growth22.9%
Revenue growth rate4.0%
Future return on equity12.6%
Analyst coverage

Low

Last updated22 Jul 2024

Recent future growth updates

No updates

Recent updates

Earnings and Revenue Growth Forecasts

BATS-CHIXE:MEDXZ - Analysts future estimates and past financials data (CHF Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/202654033481132
12/31/202551630441062
12/31/20244912037962
6/30/2024480-21569N/A
3/31/2024483-1963N/A
12/31/20234870356N/A
9/30/20234815-347N/A
6/30/202347510-937N/A
3/31/202347611042N/A
12/31/202247712948N/A
9/30/2022478212257N/A
6/30/2022480313666N/A
3/31/2022468374676N/A
12/31/2021457445587N/A
9/30/2021435365690N/A
6/30/2021414285794N/A
3/31/2021382193272N/A
12/31/202035110851N/A
12/31/2019421255389N/A
12/31/2018454526494N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: MEDXZ is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (1.9%).

Earnings vs Market: MEDXZ is forecast to become profitable over the next 3 years, which is considered above average market growth.

High Growth Earnings: MEDXZ is expected to become profitable in the next 3 years.

Revenue vs Market: MEDXZ's revenue (4% per year) is forecast to grow faster than the UK market (3.6% per year).

High Growth Revenue: MEDXZ's revenue (4% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: MEDXZ's Return on Equity is forecast to be low in 3 years time (12.6%).


Discover growth companies